Share this post on:

Product Name :
Cetuximab sarotalocan

Search keywords :
IRDye 700DX

drugId :
null

Target Vo:
Epidermal growth factor receptor erbB1

Target Vo Short Name :
EGFR

Moa_Name:
Epidermal growth factor receptor erbB1 antagonists

First Approval Country :
Japan

First Approval Date Filter:
2020

Origin Company_Name :
Aspyrian Therapeutics

Active Company_Name :
Hikma Pharmaceuticals Plc

Active Indication_Name:
Head and Neck Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PFKFB3 Rabbit mAb References
Burosumab web
Estrogen Receptor alpha Antibody: Estrogen Receptor alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 66 kDa, targeting to Estrogen Receptor alpha. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP,ChIP assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related